Main
>
A1. CORP. INDEX. C-Cm No. 1
>
CellTrion Inc./P C2
CellTrion Inc./P C2's subsections
2008. 01.10. CSL Collab
2016. 04.05. Arthritis BioSimilar
2018. 02.14. Onco. BioSimilar
2019. 09.30. AIDS USA Launch
2020. 03.23. COVID-19 Treat.
2020. 04.13. COVID-19 Treat.
2023. 10.22. U.S. FDA Approval
Web-Site
CellTrion Inc./P C2's products
This section has no products
2008. 01.10. CSL Collab
2016. 04.05. Arthritis BioSimilar
2018. 02.14. Onco. BioSimilar
2019. 09.30. AIDS USA Launch
2020. 03.23. COVID-19 Treat.
2020. 04.13. COVID-19 Treat.
2023. 10.22. U.S. FDA Approval
Web-Site